Tue, Sep 29|
NEW VIRTUAL PROGRAM ~ PADCEV - enfortumab vedotin-eifv
YOU ARE CORDIALLY INVITED TO A VIRTUAL PROGRAM A program on an FDA-approved treatment option in locally advanced or mUC for patients who have previously received a PD-1 or PD-L1 inhibitor and a platinum- containing chemotherapy in the neoadjuvant/adjuvant, locally advanced, or metastatic setting.
Time & Location
Sep 29, 2020, 6:00 PM
About The Event
Bethany Mooney, RNP Medical Oncology Nurse Practitioner Penn Medicine Philadelphia, PA
Register in advance for this meeting: Link: Meeting Registration After registering, you will receive a confirmation email containing information about joining the meeting.
Kindly Reply by
09/22/2020 In the RSVP, please include your Name, Contact Information, Organization, and Specialty.